Global Continuous Renal Replacement Therapy Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Continuous Renal Replacement Therapy Market is presumed to reach the market size of nearly USD 10.94 BN by 2030 from USD 4.41 BN in 2022 with a CAGR of 10.62% under the study period of 2023 - 2030.

Continuous renal replacement therapy (CRRT) is a well-known treatment option for critically ill patients with acute kidney injury who require renal support, particularly hemodynamically unstable patients, to provide renal support. The main benefit of continuous renal replacement therapy is that it removes fluid or solute at a slower rate per unit time. CRRT technique could filter the toxins from fluids. CRRT, on the other hand, can last up to 24 hours.

MARKET DYNAMICS:

The increased prevalence of chronic kidney disease, a major risk factor for diabetes, hypertension, cardiovascular disease, and inflammatory kidney disease, is expected to drive the demand for continuous renal replacement therapy in the upcoming years. Moreover, with the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly and propel the continuous renal replacement therapy (CRRT) market growth during the forecast period. Furthermore, well-established healthcare infrastructure and high adoption rates of new technologies in continuous renal replacement therapy propel the market growth. In addition, the high number of initiatives taken by the manufacturers and government during the pandemic to increase awareness regarding CRRT is expected to boost the growth of the market for continuous renal replacement therapy. However, the high cost associated with continuous renal replacement therapy procedures will impede the growth of the renal replacement therapy market.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of continuous renal replacement therapy. The growth and trends of Continuous Renal Replacement Therapy Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the continuous renal replacement therapy market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Dialysates And Replacement Fluids
Disposables
Hemofilters
Bloodline Sets & Tubes
Other Disposables
Crrt Systems

By Modality

Continuous Venovenous Hemofiltration (CVVH)
Continuous Venovenous Hemodiafiltration (CVVHDF)
Continuous Venovenous Haemodialysis (CVVHD)
Slow Continuous Ultrafiltration (SCUF)

By Age Group

Adults
Pediatrics /Neonates

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Continuous Renal Replacement Therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the continuous renal replacement therapy market include Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. S.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China), among others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218337

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CONTINUOUS RENAL REPLACEMENT THERAPY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Modality
- 3.7.3 Market Attractiveness Analysis By Age group
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY PRODUCT

6.1 Overview by Product
6.2 Historical and Forecast Data
6.3 Analysis by Product
6.4 Dialysates And Replacement Fluids Historic and Forecast Sales by Regions
6.5 Disposables Historic and Forecast Sales by Regions
6.6 Hemofilters Historic and Forecast Sales by Regions
6.7 Bloodline Sets & Tubes Historic and Forecast Sales by Regions
6.8 Other Disposables Historic and Forecast Sales by Regions
6.9 CRRT Systems Historic and Forecast Sales by Regions

7 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY MODALITY

7.1 Overview by Modality
7.2 Historical and Forecast Data
7.3 Analysis by Modality
7.4 Continuous Venovenous Hemofiltration (CVVH) Historic and Forecast Sales by Regions
7.5 Continuous Venovenous Hemodiafiltration (CVVHDF) Historic and Forecast Sales by Regions
7.6 Continuous Venovenous Haemodialysis (CVVHD) Historic and Forecast Sales by Regions
7.7 Slow Continuous Ultrafiltration (SCUF) Historic and Forecast Sales by Regions

8 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY AGE GROUP

8.1 Overview by Age group
8.2 Historical and Forecast Data
8.3 Analysis by Age group
8.4 Adults Historic and Forecast Sales by Regions
8.5 Pediatrics /Neonates Historic and Forecast Sales by Regions

9 . GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CONTINUOUS RENAL REPLACEMENT THERAPY COMPANIES

10.1. Continuous Renal Replacement Therapy Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CONTINUOUS RENAL REPLACEMENT THERAPY INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Baxter International Inc. (US)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Fresenius Medical Care AG & Co. KGaA (Germany)
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. NIKKISO CO. LTD. (Japan)
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. B. Braun Melsungen AG (Germany)
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Asahi Kasei Corporation (Japan)
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Toray Medical Co. Ltd. (Japan)
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Infomed SA (Switzerland)
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Medtronic plc (Ireland)
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. Medica S.p.A. (Italy)
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Medical Components Inc. (US)
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments
11.13. Medites Pharma spol. s.r.o. (Czech Republic)
- 11.13.1. Company Overview
- 11.13.2. Company Revenue
- 11.13.3. Products
- 11.13.4. Recent Developments
11.14. SWS Hemodialysis Care Co. Ltd. (China)
- 11.14.1. Company Overview
- 11.14.2. Company Revenue
- 11.14.3. Products
- 11.14.4. Recent Developments
11.15. Ningbo Tianyi Medical Devices Co. Ltd. (China)
- 11.15.1. Company Overview
- 11.15.2. Company Revenue
- 11.15.3. Products
- 11.15.4. Recent Developments
11.16. Nipro Corporation (Japan)
- 11.16.1. Company Overview
- 11.16.2. Company Revenue
- 11.16.3. Products
- 11.16.4. Recent Developments
11.17. Anjue Medical Equipment Co. Ltd. (China)
- 11.17.1. Company Overview
- 11.17.2. Company Revenue
- 11.17.3. Products
- 11.17.4. Recent Developments
11.18. Others
- 11.18.1. Company Overview
- 11.18.2. Company Revenue
- 11.18.3. Products
- 11.18.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies